Bausch Health Companies I... (BHC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 6.12 |
Market Cap | 2.33B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.48 |
PE Ratio (ttm) | -13.19 |
Forward PE | n/a |
Analyst | Hold |
Ask | 6.7 |
Volume | 1,322,573 |
Avg. Volume (20D) | 2,138,203 |
Open | 6.43 |
Previous Close | 6.45 |
Day's Range | 6.19 - 6.45 |
52-Week Range | 3.96 - 11.46 |
Beta | undefined |
About BHC
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on...
Analyst Forecast
According to 5 analyst ratings, the average rating for BHC stock is "Hold." The 12-month stock price forecast is $8, which is an increase of 26.38% from the latest price.
Next Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
Why Price Moved
News

1 day ago · accessnewswire.com
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars ProgramBausch Health to Provide Scholarships to 10 Students Living with GI Diseases LAVAL, QC / ACCESS Newswire / February 10, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology...

2 weeks ago · accessnewswire.com
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025LAVAL, QC / ACCESS Newswire / January 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2024 financial results after market close on Wednesday, Febr...

4 weeks ago · businesswire.com
Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap BiosciencesVAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an affiliate h...